Cancer Profile in Jakarta: A 5-year Descriptive Study
DOI:
https://doi.org/10.3889/oamjms.2023.8200Keywords:
cancer profile, cancer registry, jakartaAbstract
BACKGROUND: According to the World Health Organization reports in 2020, cancer was the second leading cause of death in developing countries following cardiovascular diseases and infections. As one of the strategies to prioritize cancer control in Indonesia, it is crucial to establish a population-based cancer registry, thus necessitating a well-recorded study with a robust methodology of documentation and reporting of cancer profile.
AIM: This study aims to describe the cancer profile in Jakarta based on the data from Cipto Mangunkusumo Hospital as the cancer registry control center for Jakarta Capital Region.
METHODS: We conducted a cross-sectional and descriptive study by collecting data from the cancer registry in Cipto Mangunkusumo Hospital, which were pooled from five subregional hospitals in Jakarta from 2008 to 2012. Statistical analysis was performed using IBM SPSS Statistics 20.0.
RESULTS: We obtained data from 15,042 cancer patients in Jakarta with a male-to-female ratio of 1:1.8. The majority of patients were from the group of 45–54 years old. Late-stage presentation (stages III and IV) was observed in 24.6% of patients. The highest number of patients was from West Jakarta (27.7%), followed by East Jakarta (26.1%). The five most common cancer found in both sexes was breast cancer, cervical cancer, hematopoietic and reticuloendothelial system malignancy, lung and bronchial cancer, and nasopharyngeal cancer.
CONCLUSION: The findings from this study correspond to GLOBOCAN 2012 for South-east Asia Region, particularly regarding the male-to-female ratio and patients’ age group. However, we highlighted the need to optimize data collection by involving all health-care facilities in Jakarta.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492 PMid:30207593 DOI: https://doi.org/10.3322/caac.21492
International Agency for Research on Cancer. Cancer Today. Lyon, France: International Agency for Research on Cancer; 2021. Available from: https://www.gco.iarc.fr/today/home [Last accessed on 2021 Feb 23].
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012: IARC CancerBase No. 11. International Agency for Research Cancer; 2014. Available from: https://www.globocan.iarc.fr [Last accessed on 2017 Apr 15].
Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, et al. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer. 2010;127(12):2918-27. https://doi.org/10.1002/ijc.25517 PMid:21351270 DOI: https://doi.org/10.1002/ijc.25517
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer.
Lancet. 2019;393(10167):169-82. https://doi.org/10.1016/S0140-6736(18)32470-X PMid:30638582 DOI: https://doi.org/10.1016/S0140-6736(18)32470-X
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. https://doi.org/10.1002/ijc.29210 PMid:25220842 DOI: https://doi.org/10.1002/ijc.29210
National Institute of Health Research and Development. Basic Health Research (Riskesdas) 2013. Jakarta: National Institute of Health Research and Development; 2013.
National Institute of Health Research and Development. Basic Health Research (Riskesdas) 2018. Jakarta: Ministry of Health, Republic of Indonesia; 2018.
Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217-22. https://doi.org/10.2991/jegh.k.191008.001 PMid:31854162 DOI: https://doi.org/10.2991/jegh.k.191008.001
Sabrida H. Peranan deteksi dini kanker untuk menurunkan penyakit kanker stage lanjut. In: The Ministry of Health of the Republic of Indonesia, editor. Buletin Jendela Data dan Informasi Kesehatan. Jakarta: The Ministry of Health of the Republic of Indonesia; 2015, p. 16-24.
National Cancer Institute. Cancer Statistics Facts: Leukemia. Surveillance, Epidemiol End Results Program. Bethesda, Maryland: National Cancer Institute; 2014. Available from: https://www.seer.cancer.gov/statfacts/html/leuks.html [Last accessed on 2017 Apr 16].
Imsamran W, Chaiwerawattana A, Wiangnon S, Pongnikorn D, Suwanrungrung K, Sangrajrang S, et al. Cancer in Thailand Vol VIII, 2010-2012. Bangkok: Cancer Registry Unit, National Cancer Institute Thailand; 2015.
Dinas Kesehatan DKI Jakarta. Jakarta Health Profile 2019. Jakarta: Dinas Kesehatan DKI Jakarta; 2021.
Perez C, Kavanagh B. Uterine cervix. In: Halperin E, Wazer D, Perez C, Brady L, editors. Perez Brady’s Principles and Practice Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008, p. 1532-1609.
Chang J, Bradley J, Govidan R, Komaki R, Halperin E, Wazer D, et al. Lung. In: Halperin E, Wazer D, Perez C, Brady L, editors. Perez Brady’s Principles and Practice Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 2167-75.
Lee A, Perez C, Law S, Chua D, Wei W, Chong V. Nasopharynx. In: Halperin E, Wazer D, Perez C, Brady L, editors. Perez Brady’s Principles and Practice Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008, p. 701-9.
Roberts K, Seropian S. Leukemia. In: Halperin E, Wazer D, Perez C, Brady L, editors. Perez Brady’s Principles and Practice Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 3455-6.
Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943-55. https://doi.org /10.1016/ S0140-6736(12)62187-4 DOI: https://doi.org/10.1016/S0140-6736(12)62187-4
Thaker H, Lin S. Early-stage (I-II) non-small cell lung cancer. In: Hristov B, Lin S, Christodouleas J, editors. Radiation Oncology: A Question-based Review. 2nd ed. Philadelphia: Wolters Kluwer Health; 2015, p. 207-20.
Horesh N, Horowitz NA. Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5(4):e0038. https://doi.org/10.5041/RMMJ.10172 PMid:25386354 DOI: https://doi.org/10.5041/RMMJ.10172
Bray F, Haugen M, Moger TA, Tretli S, Aalen OO, Grotmol T.
Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2356-65. https://doi.org/10.1158/1055-9965.EPI-08-0461 PMid:18768504 DOI: https://doi.org/10.1158/1055-9965.EPI-08-0461
Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012;31(4):185-96. https://doi.org/10.5732/cjc.011.10328 PMid:22313595 DOI: https://doi.org/10.5732/cjc.011.10328
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Soehartati Gondhowiardjo, Wahyudi Nurhidayat, Nadiyya Faza Zhafirah, Vito Filbert Jayalie, Sri Mutya Sekarutami, R. Koesmedi Priharto, Widyastuti Widyastuti (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
